TLDR Chronic hair shedding may be caused by less variation in hair growth times and might stop on its own after several years.
The study from 2010 used a computational model to simulate hair follicle dynamics and suggested that Chronic Telogen Effluvium (CTE) is caused by a reduction in the variance of anagen duration, with these durations being relatively constant at around 16 months. This condition is characterized by acute exacerbations and periodicity in hair shedding but does not lead to significant long-term loss in hair volume. The model indicates that CTE might resolve spontaneously after about a decade, although this lacks clinical data confirmation. The cause of the altered follicular dynamics is unknown, but it may represent a new pathological type of hair shedding in humans, proposing that CTE and Diffuse Cyclic Hair Loss (DCHL) be classified as a new functional type of hair loss. Further clinical data is needed to validate the model.
Cited in this study
6 / 6 results
137 citations
,
August 2004 in “Journal of The American Academy of Dermatology” Horizontally sectioned scalp biopsies are more reliable for diagnosing hair loss in women when three samples are taken instead of one.
144 citations
,
July 2002 in “Clinical and Experimental Dermatology” Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.
22 citations
,
February 2002 in “Journal of theoretical biology” The model showed that randomness accurately describes individual hair growth cycles and that synchronization can cause large fluctuations not seen in humans.
83 citations
,
May 1999 in “International Journal of Dermatology” Hair loss that spreads out can often fix itself or be treated by finding and handling the cause.
234 citations
,
December 1996 in “Journal of The American Academy of Dermatology” Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.
214 citations
,
March 1993 in “Archives of Dermatology” Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.
January 2022 in “Elsevier eBooks” The document's conclusion cannot be summarized because it is not readable or understandable.
August 2021 in “Pharmacy Today” The document's conclusion about hair loss cannot be determined.
2 citations
,
December 2018 in “Seminars in Cutaneous Medicine and Surgery”
January 2016 The article concludes that understanding the causes of hair loss and using continuous treatments like minoxidil and finasteride can help manage it, despite potential side effects.
August 2013 in “Pharmacy Today” Viviscal may modestly improve hair loss in women without adverse effects.
54 citations
,
January 2013 in “Dermatologic Clinics” Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.